Literature DB >> 28971119

Raman and Infrared spectroscopies and X-ray diffraction data on bupivacaine and ropivacaine complexed with 2-hydroxypropyl-β-cyclodextrin.

Murillo L Martins1, Juergen Eckert2,3, Henrik Jacobsen1, Everton C Dos Santos1,4, Rosanna Ignazzi1, Daniele Ribeiro de Araujo5, Marie-Claire Bellissent-Funel6, Francesca Natali7,8, Michael Marek Koza8, Aleksander Matic9, Eneida de Paula10, Heloisa N Bordallo1,11.   

Abstract

The data presented in this article are related to the research article entitled "Probing the dynamics of complexed local anesthetics via neutron scattering spectroscopy and DFT calculations (http://dx.doi.org/10.1016/j.ijpharm.2017.03.051)" (Martins et al., 2017) [1]. This work shows the molecular and structural behavior of the local anesthetics (LAs) bupivacaine (BVC, C18H28N2O) and ropivacaine (RVC, C17H26N2O) before and after complexation with the water-soluble oligosaccharide 2-hydroxypropyl-β-cyclodextrin (HP-β-CD).

Entities:  

Year:  2017        PMID: 28971119      PMCID: PMC5609877          DOI: 10.1016/j.dib.2017.08.053

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data Relevant data on the characterization of local anesthetics RVC and BVC and the respective complexes. Data to be used on understanding molecular changes on local anesthetics after complexation in HP-β-CD. RS, FTIR and XRD data to be used as complementary information to several characterization techniques on pharmaceutical research.

Data

FTIR and Raman spectra for BVC, RVC and HP-β-CD are presented in Fig. 1 (a) and (b) to be used as complemmentary data for the neutron scattering analysis presented on reference [1]. Table 1 presents the modes assignment, based on references [2], [3], [4]. Fig. 2(a) presents FTIR data for BVC and RVC BVC after complexation with HP-β-CD, thus BVC-HP-β-CD and RVC-HP-β-CD. Fig. 2(b) shows the respective RS spectra. In Fig. 3, X-ray diffraction data is presented for BVC-HP-β-CD and RVC-HP-β-CD, i.e. RVC after complexation with HP-β-CD.
Fig. 1

(a) FTIR and (b) Raman spectra of RVC, BVC and HP-β-CD. All data were collected at room temperature.

Table 1

Modes assignment for FTIR and RS for BVC, RVC and HP-β-CD.

SampleFrequencies (cm-1)Modes Assignment
BVC and RVC

3509 (BVC)

3512 (RVC)

O-H bond stretching

3240 and 3318 (BVC)

3199, 3278 and 3326 (RVC)

Stretching of hydrogen-bonded N-H group of the mono-substituted amides, O=C-N-H
2960CH3stretching
2500 - 2700Stretching of N-H-Cl
1700 - 1600C=C and C=O stretching
1680 – 1630Amide carbonyl stretching band (□(C=O))
1550Amide II vibration (C-N stretching vibrations together with N-H bending)
1250C-N-H stretch vibrations
1470 - 1250Information on the rings and the methyl (CH3) and methylene (CH2) groups
1466, 1436 and 1471CH2-bending

1371 (BVC)

1399 (RVC)

CH3bending
1000 – 600Bending of C-H groups located either in the rings or in the carbon groups
Around 780Adjacent CH wag modes







HP-β-CD3332O-H bond vibration
2928C-H out of phase stretching
1450 and 1328C-H bending
1153, 1079 and 1014C-O stretching
vibrations below 1000Different types of bending of C-H bonds in the aromatic ring.
Fig. 2

FTIR(a) and RS(b) data for RVC and BVC after complexation with HP-β-CD, thus RVC-HP-β-CD and BVC-HP-β-CD.

Fig. 3

X-ray diffraction data for BVC after complexation with HP-β-CD (BVC-HP-β-CD) and for RVC after complexation with HP-β-CD (RVC-HP-β-CD). The data were collected with Cu radiation (λ = 1.54 Å). A baseline was subtracted from the data for background correction and BVC-HP-β-CD data was shifted for better visualization.

(a) FTIR and (b) Raman spectra of RVC, BVC and HP-β-CD. All data were collected at room temperature. FTIR(a) and RS(b) data for RVC and BVC after complexation with HP-β-CD, thus RVC-HP-β-CD and BVC-HP-β-CD. X-ray diffraction data for BVC after complexation with HP-β-CD (BVC-HP-β-CD) and for RVC after complexation with HP-β-CD (RVC-HP-β-CD). The data were collected with Cu radiation (λ = 1.54 Å). A baseline was subtracted from the data for background correction and BVC-HP-β-CD data was shifted for better visualization. Modes assignment for FTIR and RS for BVC, RVC and HP-β-CD. 3509 (BVC) 3512 (RVC) 3240 and 3318 (BVC) 3199, 3278 and 3326 (RVC) 1371 (BVC) 1399 (RVC)

Experimental design, materials and methods

Materials

BVC hydrochloride monohydrate in the form of racemate (BVC.HCl, C18H28N2O.HCl.H2O) and RVC hydrochloride monohydrate (RVC.HCl, C17H26N2O·HCl·H2O) were donated by Cristália Prod. Quím. Farm. Ltda (Itapira, SP, Brazil). 2-hydroxypropyl−β−cyclodextrin, HP-β-CD, (Kleptose HP®) was obtained from Roquette Serv. Tech. Lab. (Lestrem, Cedex, France). Deionized water (Elga Maxima System, Elga, High Wycombe, UK) was used throughout the experiments. All other reagents were of analytical grade.

Sample preparation

Samples were prepared as described in [5]. Inclusion complexes were prepared by stirring equimolar amounts of the local anesthetics (racemate BVC.HCl and RVC.HCl) and HP-β-CD (1:1 M ratio) in deionized water at room temperature (25 ± 1) ◦C for 24 h. After completely dissolution and reaching equilibrium (4 h), the solution was freeze-dried (Labconco-freeze dry system/Freezone® 4.5) and stored at -20 ◦C until further use.

Fourier Transformed Infrared Spectroscopy (FTIR)

FTIR spectra were collected to all samples at room temperature between 400 and 4000 cm-1, using an ATR Crystal from Bruker. For each sample 500 scans were carried out. A background measurement was collected at the beginning of the experiment, and the obtained signal was subsequently subtracted from all the other measurements.

Raman Scattering (RS)

RS between 200 and 3500 cm-1 were collected at room temperature using a MultiRAM FT-Raman spectrometer from Bruker equipped with a Nd:YAG laser. An incident wavelength of 1064 nm was used to measure the powder samples that were carefully mounted inside of glass vials. The powder samples were put in small glasses and a laser power of 250 mW was used to measure the HP-β-CD and the LA samples. Due to the lower density of the complex BVC-HP-β-CD, very thin pellets were made with the encapsulated drugs powders and a laser power of 500 mW was used. The data analysis was only qualitative in this experiment.

X-ray diffraction

BVC and RVC after complexation with HP-□-CD were investigated by X-ray powder diffraction (XPD) in a Brucker – D8 Discover diffractometer (Cu radiation – λ = 1.54 Å). The experiments were conduct with a 0.01° step, between 10° and 55°. A baseline was subtracted from the data for background correction and BVC-HP-β-CD data was shifted for better visualization.
Subject areaPhysics, chemistry and pharmaceutics
More specific subject areaMolecular vibration on complexed local anesthetics
Type of dataFigures and table
How data was acquiredThe Raman spectroscopy (RS) data were obtained on a MultiRAM FT spectrometer, Bruker, equipped with a Nd:YAG laser. The Fourier transformed infrared spectroscopy (FTIR) data was acquired on an ATR Crystal spectrometer, Bruker. The X-ray diffraction (XRD) data was collected on a D8 – Discover diffractometer, Bruker.
Data formatRaw and analysed data
Experimental factorsPowder samples
Experimental featuresRS was collected between 200 and 3500 cm-1with an incident wavelength of 1064 nm and a laser powers of 250 mW. FTIR data were collected between 400 and 4000 cm-1with 500 scans for each sample. XRD data was collected with a Cu radiation source.
Data source locationCopenhagen, Denmark.
Data accessibilityData are available in this article.
Related research articleProbing the dynamics of complexed local anesthetics via neutron scattering spectroscopy and DFT calculations
  4 in total

1.  Probing the dynamics of complexed local anesthetics via neutron scattering spectroscopy and DFT calculations.

Authors:  Murillo L Martins; Juergen Eckert; Henrik Jacobsen; Éverton C Dos Santos; Rosanna Ignazzi; Daniele Ribeiro de Araujo; Marie-Claire Bellissent-Funel; Francesca Natali; Michael Marek Koza; Aleksander Matic; Eneida de Paula; Heloisa N Bordallo
Journal:  Int J Pharm       Date:  2017-03-31       Impact factor: 5.875

2.  Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.

Authors:  Mario Jug; Francesca Maestrelli; Marco Bragagni; Paola Mura
Journal:  J Pharm Biomed Anal       Date:  2009-11-18       Impact factor: 3.935

3.  Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.

Authors:  Daniele R de Araujo; Simone S Tsuneda; Cíntia M S Cereda; Fernanda Del G F Carvalho; Paulo S C Preté; Sergio A Fernandes; Fabiano Yokaichiya; Margareth K K D Franco; Irineu Mazzaro; Leonardo F Fraceto; Angélica de F A Braga; Eneida de Paula
Journal:  Eur J Pharm Sci       Date:  2007-10-07       Impact factor: 4.384

4.  Characterization of four crystal polymorphs and a monohydrate of s-bupivacaine hydrochloride (levobupivacaine hydrochloride).

Authors:  V Niederwanger; F Gozzo; U J Griesser
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

  4 in total
  2 in total

1.  Fabrication of Ropivacaine/Dexamethasone-Eluting Poly(D, L-lactide-co-glycolide) Microparticles via Electrospraying Technique for Postoperational Pain Control.

Authors:  Shih-Jyun Shen; Ying-Chao Chou; Shih-Chieh Hsu; Yu-Ting Lin; Chia-Jung Lu; Shih-Jung Liu
Journal:  Polymers (Basel)       Date:  2022-02-11       Impact factor: 4.329

2.  Anisotropic microparticles for differential drug release in nerve block anesthesia.

Authors:  Shivakumar B S; Vignesh Gopalakrishnan-Prema; Gayathri Raju; Sumi E Mathew; Neeraj Katiyar; Deepthy Menon; Sahadev A Shankarappa
Journal:  RSC Adv       Date:  2021-01-22       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.